Palantir’s AI valuation problem may finally be easing

A new partnership is winning over detractors who had claimed that Palantir asked investors to pay too much for future development.
JD Supra

Same Office Action, Different Stakes: Responding to USPTO Office Actions in Ex Parte Reexamination and Ordinary Patent Prosecution

This article explains why responding to an Office Action in ex parte reexamination requires a different strategy than ...